TaiGen Biopharmaceuticals Holdings Limited (TPEX: 4157)

TaiGen Biopharmaceuticals Holdings Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 9, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	10,409	10,911	11,505	11,039	16,380	13,190
Market Cap Growth	-15.01%	-5.16%	4.22%	-32.60%	24.19%	8.25%
Enterprise Value	9,373	10,169	10,545	10,032	15,984	12,501
Last Close Price	14.50	15.20	16.05	15.40	22.85	18.40
PE Ratio	45.93	80.00	-48.51	14.26	-40.46	-44.61
PS Ratio	72.10	88.61	317.56	8.53	699.34	649.30
PB Ratio	8.83	9.75	11.86	8.81	37.04	16.18
P/FCF Ratio	-54.93	3055.51	-466.58	17.84	-66.17	-38.08
P/OCF Ratio	-55.22	1462.83	-540.94	17.55	-67.66	-38.51
EV/Sales Ratio	62.71	82.59	291.05	7.75	682.43	615.37
EV/EBITDA Ratio	-65.89	-61.79	-39.42	11.03	-54.09	-47.18
EV/EBIT Ratio	-62.47	-58.21	-37.98	11.15	-52.01	-45.11
EV/FCF Ratio	-47.34	2847.73	-427.63	16.21	-64.57	-36.09
Debt / Equity Ratio	0.06	0.07	0.04	0.04	0.04	0.08
Debt / EBITDA Ratio	-	-	-	0.06	-	-
Debt / FCF Ratio	-0.34	20.91	-1.56	0.09	-0.07	-0.19
Asset Turnover	0.13	0.11	0.03	1.33	0.03	0.02
Inventory Turnover	0.41	0.46	0.22	0.78	0.36	-
Quick Ratio	19.37	22.38	17.97	13.41	3.86	7.53
Current Ratio	20.34	23.19	18.50	13.71	4.13	7.88
Return on Equity (ROE)	22.14%	13.09%	-21.33%	91.47%	-64.39%	-30.99%
Return on Assets (ROA)	-8.42%	-9.59%	-14.23%	57.68%	-25.57%	-16.23%
Return on Capital (ROIC)	-8.73%	-9.92%	-14.99%	63.65%	-28.65%	-17.54%
Earnings Yield	2.18%	1.25%	-2.06%	7.03%	-2.47%	-2.24%
FCF Yield	-1.90%	0.03%	-0.21%	5.61%	-1.51%	-2.63%
Buyback Yield / Dilution	-6.98%	-0.06%	0.07%	-0.07%	-0.01%	-0.01%
Total Shareholder Return	-6.98%	-0.06%	0.07%	-0.07%	-0.01%	-0.01%

Source: S&P Capital IQ. Standard template. Financial Sources.